Methodist Le Bonheur Healthcare approved to bring precision radiology treatment to Germantown Hospital

Posted on: February 28, 2019

Methodist Le Bonheur Healthcare was today approved to bring precision MRI-guided radiation therapy treatment to Methodist Le Bonheur Germantown Hospital. The approval allows MLH to initiate the addition of an MRI/RT Linear Accelerator to be added to the hospital’s megavoltage radiation therapy services. 

“We’re incredibly excited to receive this approval as we continue our work to create a comprehensive cancer program focused on providing expert cancer care across all of the communities we serve,” said MLH President & CEO Michael Ugwueke. “Adding a linear accelerator to our Germantown Hospital will enable us to bring advanced treatment options out East and continue to elevate care in Germantown and surrounding areas just as we have done for more than 20 years.”

With the addition of the MRI/RT Linear Accelerator, MLH becomes the first to bring this innovative technology to Tennessee, allowing the healthcare system to provide a full spectrum of the very best in radiation oncology technology available.

“This is part of our continued commitment to bring the most advanced treatment options to patients and families across the Mid-South regardless of ability to pay,” added Ugwueke. “We are proud to be part of an elite list of cancer centers across the country in offering this treatment.”

Linear Accelerators are a type of external beam radiation therapy that delivers a beam of high energy x-rays directly to the location of a tumor or other tissue being irradiated. The technology images soft tissue, not just the bone and air that conventional technology captures to improve treatment accuracy and reduce the amount of radiation to which a patient is exposed.

This approval marks an important milestone as MLH works to create the new Methodist Cancer Institute in partnership with The University of Tennessee Health Science Center (UTHSC). As a 100 year old institution that provided care through nearly 2.2 million patient encounters in 2018, MLH is well positioned to elevate Education, Research and Clinical services and achieve its vision of building a National Cancer Institute-designated Comprehensive Cancer Center – one of only 49 in in the country. 

Related Articles